Search research articles
Contact Us
Filters
Showing results (71-80 of 440) with videos related to
Page
of 44
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 3, 2009
Supportive therapies in multiple myeloma
Charise Gleason, Ajay Nooka, Sagar Lonial
Cancer Journal (Sudbury, Mass.)
|
December 17, 2009
The importance of complete response in outcomes in myeloma
Ajay Nooka, Jonathan Kaufman, Sagar Lonial
Expert Opinion on Investigational Drugs
|
March 13, 2012
Panobinostat for the treatment of multiple myeloma
Paola Neri, Nizar J Bahlis, Sagar Lonial
Clinical Lymphoma & Myeloma
|
March 2, 2006
Novel treatment approaches for patients with multiple myeloma
Rajni Sinha, Jonathan L Kaufman, Sagar Lonial
Leukemia Research
|
May 18, 2010
Combined proteasome and histone deacetylase inhibition: A promising synergy for patients with relapsed/refractory multiple myeloma
Sundar Jagannath, Meletios A Dimopoulos, Sagar Lonial
Blood
|
August 15, 2015
How I treat high-risk myeloma
Sagar Lonial, Lawrence H Boise, Jonathan Kaufman
Clinical Lymphoma, Myeloma & Leukemia
|
February 12, 2022
Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Meletios-Athanasios Dimopoulos, Paul Richardson, Sagar Lonial
Clinical Lymphoma, Myeloma & Leukemia
|
September 1, 2020
Message from the Chairmen
Sagar Lonial, Hagop Kantarjian, Emil J Freireich
Clinical Advances in Hematology & Oncology : H&O
|
March 19, 2021
Antibody treatment in multiple myeloma
Kathryn T Maples, Catherine Johnson, Sagar Lonial
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma
Paola Neri, Nizar J Bahlis, Sagar Lonial
Page
of 44
Search research articles
Search
Showing results (71-80 of 440) with videos related to
Sort By:
Page
of 44
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 3, 2009
Supportive therapies in multiple myeloma
Charise Gleason, Ajay Nooka, Sagar Lonial
Cancer Journal (Sudbury, Mass.)
|
December 17, 2009
The importance of complete response in outcomes in myeloma
Ajay Nooka, Jonathan Kaufman, Sagar Lonial
Expert Opinion on Investigational Drugs
|
March 13, 2012
Panobinostat for the treatment of multiple myeloma
Paola Neri, Nizar J Bahlis, Sagar Lonial
Clinical Lymphoma & Myeloma
|
March 2, 2006
Novel treatment approaches for patients with multiple myeloma
Rajni Sinha, Jonathan L Kaufman, Sagar Lonial
Leukemia Research
|
May 18, 2010
Combined proteasome and histone deacetylase inhibition: A promising synergy for patients with relapsed/refractory multiple myeloma
Sundar Jagannath, Meletios A Dimopoulos, Sagar Lonial
Blood
|
August 15, 2015
How I treat high-risk myeloma
Sagar Lonial, Lawrence H Boise, Jonathan Kaufman
Clinical Lymphoma, Myeloma & Leukemia
|
February 12, 2022
Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Meletios-Athanasios Dimopoulos, Paul Richardson, Sagar Lonial
Clinical Lymphoma, Myeloma & Leukemia
|
September 1, 2020
Message from the Chairmen
Sagar Lonial, Hagop Kantarjian, Emil J Freireich
Clinical Advances in Hematology & Oncology : H&O
|
March 19, 2021
Antibody treatment in multiple myeloma
Kathryn T Maples, Catherine Johnson, Sagar Lonial
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2016
New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma
Paola Neri, Nizar J Bahlis, Sagar Lonial
Page
of 44